139 related articles for article (PubMed ID: 15940254)
21. Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway.
Kasper G; Reule M; Tschirschmann M; Dankert N; Stout-Weider K; Lauster R; Schrock E; Mennerich D; Duda GN; Lehmann KE
BMC Cancer; 2007 Jan; 7():12. PubMed ID: 17233884
[TBL] [Abstract][Full Text] [Related]
22. Gene expression profiling of tumours derived from rasV12/E1A-transformed mouse embryonic fibroblasts to identify genes required for tumour development.
Vasseur S; Malicet C; Calvo EL; Dagorn JC; Iovanna JL
Mol Cancer; 2005 Jan; 4(1):4. PubMed ID: 15651998
[TBL] [Abstract][Full Text] [Related]
23. Aberrant intracellular IGF-1R beta-subunit makes receptor knockout cells (IGF1R-/-) susceptible to oncogenic transformation.
Natalishvili N; Axelson M; Girnita L; Larsson O; Vasilcanu D
Exp Cell Res; 2009 May; 315(8):1458-67. PubMed ID: 19302825
[TBL] [Abstract][Full Text] [Related]
24. Insulin-like growth factor I controls a mutually exclusive association of RACK1 with protein phosphatase 2A and beta1 integrin to promote cell migration.
Kiely PA; O'Gorman D; Luong K; Ron D; O'Connor R
Mol Cell Biol; 2006 Jun; 26(11):4041-51. PubMed ID: 16705158
[TBL] [Abstract][Full Text] [Related]
25. Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).
Jernberg-Wiklund H; Nilsson K
Adv Cancer Res; 2007; 97():139-65. PubMed ID: 17419944
[TBL] [Abstract][Full Text] [Related]
26. Adhesion, migration, transcriptional, interferon-inducible, and other signaling molecules newly implicated in cancer susceptibility and resistance of JB6 cells by cDNA microarray analyses.
Samuel S; Bernstein LR
Mol Carcinog; 2004 Jan; 39(1):34-60. PubMed ID: 14694446
[TBL] [Abstract][Full Text] [Related]
27. Characterization of LMX-1A as a metastasis suppressor in cervical cancer.
Liu CY; Chao TK; Su PH; Lee HY; Shih YL; Su HY; Chu TY; Yu MH; Lin YW; Lai HC
J Pathol; 2009 Oct; 219(2):222-31. PubMed ID: 19644956
[TBL] [Abstract][Full Text] [Related]
28. The insulin-like growth factor-I receptor as an oncogene.
Werner H; Bruchim I
Arch Physiol Biochem; 2009 May; 115(2):58-71. PubMed ID: 19485702
[TBL] [Abstract][Full Text] [Related]
29. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Yamada R; Fujii S; Rino Y; Kunisaki C; Tanaka K; Masuda M; Imada T
Oncol Rep; 2008 Aug; 20(2):359-64. PubMed ID: 18636198
[TBL] [Abstract][Full Text] [Related]
31. Silencing of MBD1 and MeCP2 in prostate-cancer-derived PC3 cells produces differential gene expression profiles and cellular phenotypes.
Yaqinuddin A; Abbas F; Naqvi SZ; Bashir MU; Qazi R; Qureshi SA
Biosci Rep; 2008 Dec; 28(6):319-26. PubMed ID: 18666890
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
[TBL] [Abstract][Full Text] [Related]
33. IGF-1R tyrosine kinase expression and dependency in clones of IGF-1R knockout cells (R-).
Rosengren L; Vasilcanu D; Vasilcanu R; Fickenscher S; Sehat B; Natalishvili N; Naughton S; Yin S; Girnita A; Girnita L; Axelson M; Larsson O
Biochem Biophys Res Commun; 2006 Sep; 347(4):1059-66. PubMed ID: 16857168
[TBL] [Abstract][Full Text] [Related]
34. Conditional deletion of insulin-like growth factor-I receptor in prostate epithelium.
Sutherland BW; Knoblaugh SE; Kaplan-Lefko PJ; Wang F; Holzenberger M; Greenberg NM
Cancer Res; 2008 May; 68(9):3495-504. PubMed ID: 18451178
[TBL] [Abstract][Full Text] [Related]
35. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1.
Maor S; Mayer D; Yarden RI; Lee AV; Sarfstein R; Werner H; Papa MZ
J Endocrinol; 2006 Dec; 191(3):605-12. PubMed ID: 17170218
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of IGF-I receptor in HeLa cells enhances in vivo radioresponse.
Kaneko H; Yu D; Miura M
Biochem Biophys Res Commun; 2007 Nov; 363(4):937-41. PubMed ID: 17920037
[TBL] [Abstract][Full Text] [Related]
37. Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells.
Fang J; Zhou Q; Shi XL; Jiang BH
Carcinogenesis; 2007 Mar; 28(3):713-23. PubMed ID: 17065200
[TBL] [Abstract][Full Text] [Related]
38. Silencing of LASP-1 influences zyxin localization, inhibits proliferation and reduces migration in breast cancer cells.
Grunewald TG; Kammerer U; Schulze E; Schindler D; Honig A; Zimmer M; Butt E
Exp Cell Res; 2006 Apr; 312(7):974-82. PubMed ID: 16430883
[TBL] [Abstract][Full Text] [Related]
39. Effects of RACK1 on cell migration and IGF-I signalling in cardiomyoctes are not dependent on an association with the IGF-IR.
O'Donovan HC; Kiely PA; O'Connor R
Cell Signal; 2007 Dec; 19(12):2588-95. PubMed ID: 17900863
[TBL] [Abstract][Full Text] [Related]
40. Caveolin-1 up-regulates IGF-I receptor gene transcription in breast cancer cells via Sp1- and p53-dependent pathways.
Glait C; Tencer L; Ravid D; Sarfstein R; Liscovitch M; Werner H
Exp Cell Res; 2006 Nov; 312(19):3899-908. PubMed ID: 17014845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]